Dr. Timoney studies a range of topics within medical research, most notably in the areas of chemotherapy management, leukemia, and bacterial infections. He has contributed significantly to understanding how to reduce nausea and vomiting in chemotherapy patients through updated treatment guidelines. In addition, his research on acute myeloid leukemia (AML) has uncovered critical pathways that may help in developing new therapies. Furthermore, he works on improving the detection of bacterial diseases, particularly using innovative methods to quickly identify harmful bacteria like Streptococcus equi in clinical settings.
Key findings
Dr. Timoney's guidelines helped improve antiemetic (anti-nausea) treatment for chemotherapy patients, integrating carboplatin and granisetron.
In his AML research, targeting the E2F1 protein slowed down AML cell proliferation, highlighting potential new treatment strategies.
His rapid detection method for Streptococcus equi achieved a perfect success rate in identifying bacterial DNA from nasal swabs, only needing 50 copies for detection.
Frequently asked questions
Does Dr. Timoney study cancer treatments?
Yes, he focuses on improving therapies for conditions like acute myeloid leukemia and managing chemotherapy side effects.
What bacterial infections has Dr. Timoney researched?
He has developed rapid detection tests for infections caused by Streptococcus equi and contributed to understanding Erysipelothrix rhusiopathiae.
Are Dr. Timoney's findings useful for patients undergoing chemotherapy?
Absolutely, his research provides updated guidelines aimed at easing nausea and improving patient care during chemotherapy.
Can Dr. Timoney's work help with horse health?
Yes, his research on Streptococcus equi can assist veterinarians and horse owners in managing equine strangles effectively.
Publications in plain English
NCCN Guidelines Insights: Antiemesis, Version 2.2017.
2017
Journal of the National Comprehensive Cancer Network : JNCCN
Berger MJ, Ettinger DS, Aston J, Barbour S, Bergsbaken J +24 more
Plain English This paper discusses updated guidelines for managing nausea and vomiting caused by chemotherapy. Key updates include new information on the use of carboplatin, granisetron, and olanzapine, which help improve treatment for these common side effects. These guidelines are important because they ensure that patients receiving chemotherapy receive the best possible care to ease their discomfort.
Who this helps: Patients undergoing chemotherapy.
Regulation of Trib2 by an E2F1-C/EBPα feedback loop in AML cell proliferation.
2014
Blood
Rishi L, Hannon M, Salomè M, Hasemann M, Frank AK +6 more
Plain English This study focused on how changes in specific proteins affect the growth of acute myeloid leukemia (AML) cells. Researchers found that a protein called E2F1 increases the levels of another protein called Trib2, which helps leukemia cells survive and multiply. Blocking these proteins slowed down the growth of AML cells, highlighting potential targets for treatment in this aggressive cancer.
Who this helps: This research can benefit patients with AML by guiding new treatment strategies.
Thermophilic helicase-dependent DNA amplification using the IsoAmp™ SE experimental kit for rapid detection of Streptococcus equi subspecies equi in clinical samples.
2011
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
Artiushin S, Tong Y, Timoney J, Lemieux B, Schlegel A +1 more
Plain English This study created a new, simple test to quickly detect a bacteria called Streptococcus equi subspecies equi in clinical samples, using a portable kit called IsoAmp™ SE. The test can find as little as 50 copies of the bacterial DNA and has a perfect success rate when identifying the bacteria in nasal swabs and washes. This test is easier to use than traditional methods and speeds up the process of identifying infections, making it a valuable tool in clinical settings.
Who this helps: This helps doctors and laboratories in identifying bacterial infections faster.
Characterization of the haemolytic activity of Streptococcus equi.
1998
Microbial pathogenesis
Flanagan J, Collin N, Timoney J, Mitchell T, Mumford JA +1 more
Plain English This study looked at a bacteria called Streptococcus equi, which causes a disease in horses known as equine strangles. The researchers found that this bacteria produces a specific toxin called streptolysin S-like, which damages red blood cells, especially when grown in certain conditions with horse serum. They discovered that this toxin could be made inactive by a substance called trypan blue, and they identified two strains of the bacteria that do not produce this harmful toxin due to genetic changes.
Who this helps: This information benefits veterinarians and horse owners by improving understanding of how to manage and treat equine strangles.
The effect of decomplementation on Erysipelothrix rhusiopathiae infection in the mouse.
1970
Immunology
Timoney J
Plain English This study looked at how a process called decomplementation affects mice infected with a specific bacteria, Erysipelothrix rhusiopathiae. Researchers found that reducing complement levels in the blood made mice die faster after infection; however, the overall number of deaths was similar whether or not the mice had reduced complement. The results show that complement proteins in the blood help protect against this infection by making it easier for the immune system to recognize and attack the bacteria.
Who this helps: This helps patients with infections related to Erysipelothrix rhusiopathiae and doctors treating these patients.
Michael J Berger David S Ettinger Jonathan Aston Sally Barbour Jason Bergsbaken Philip J Bierman Debra Brandt Dawn E Dolan Georgiana Ellis Eun Jeong Kim
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.